|
|
|
|
|
|
| Externally validated program sets global standard for measuring competence of clinical monitors |
Raleigh, NC, Sept 10, 2013 - (ACN Newswire) - INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced it is the first global CRO to implement the Clinical Research Monitor Accreditation program, an internationally recognized standard for competence in clinical research monitoring offered through the International Academy of Clinical Research (IAoCR). The new Clinical Credentialing program standardizes training of clinical research associates (CRAs) and establishes INC Research as the first accredited training center in the U.S.
"INC Research is committed to providing the best clinical development services to our biopharmaceutical partners, including the most highly trained and competent monitoring staff in the industry," said Alistair Macdonald, Chief Operating Officer. "The Clinical Credential program will validate INC Research monitors' capabilities against globally recognized best practices, including recognition and reporting of adverse events, understanding regulatory processes, preparing for successful site initiations and site visits and more. Customers can therefore be confident the CRAs assigned to their studies are not only well trained and field tested, but also that their skills have been certified against an independent quality standard."
By ensuring its CRAs meet the Clinical Credentialing standard, INC is positioned to reduce risks to patients and lower error rates thereby helping to accelerate new treatments to market. Exceptional training and global recognition of skills also is expected to help attract and retain top clinical research professionals.
Launched in direct response to the industry's growing demand for accreditation of clinical research professionals, IAoCR's credentialing process focuses on independent verification of an individual's ability to monitor clinical trials effectively in real-life situations. INC Research will train its CRAs, beginning with entry-level monitors, according to the new IAoCR program, a process spanning two to three months including field tests.
"Competent monitors play an essential role in getting new treatments to market faster while protecting the rights and wellbeing of patients involved in clinical trials," said Jacqueline Johnson North, CEO of IAoCR. "That's why offering programs that regulate and standardize training for CRAs is so important. I commend INC Research for being the first global CRO to embrace this program."
Founded in 2011, IAoCR is fast becoming the globally recognized standard for accreditation of professionals working in the international clinical research industry. IAoCR courses and accreditations are recognized by educational institutes and employers globally and are mapped to international qualification frameworks. Accreditations cover the depth and breadth of clinical research competencies and provide a far more accurate prediction of performance than simply years of experience.
About IAoCR
International Academy of Clinical Research (IAoCR) aims to bring accreditation to clinical research professionals. The aim is to ensure that clinical research trainers are knowledgeable and appropriately qualified and that all training courses are focused on verification of competence. IAoCR was founded following several years of consultation with industry leaders who highlighted a need for recognized professional accreditations for clinical research monitors, project managers and trainers; and accreditation of clinical research training courses.
IAoCR accreditations are mapped to various international qualifications frameworks. They are quality assured by bodies regulated by Ofqual (Office for Qualifications and Examinations Regulation), which is recognized within the ISCED (International Standard of Education) framework produced by UNESCO (United Nations Educational, Scientific and Cultural Organization).
For further press information or to arrange an interview with a spokesperson from the IAoCR, please contact: Jo Henderson, PR Consultant - Tel: +44 (0)7870 634567 Email: jo.henderson@writewaypr.co.uk
For more information on IAoCR, visit www.iaocr.com, follow us at @iaocr or telephone +44 (0)1628 784 906.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to us for a complete range of customized Phase I to IV programs in all therapeutic areas and patient populations. Our Trusted Process(R) methodology and therapeutic foresight lead customers to better-informed product development decisions, while our solid site relationships are a critical success factor in delivering clinical trial results on time and on budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact:
Lori Dorer, Media +1-513-345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Topic: Press release summary
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
